Boothbay Fund Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2,444
Closed -$476K – 2436
2026
Q2
$476K Buy
+2,444
New +$507K 0.01% 1526
2024
Q1
– Sell
-1,444
Closed -$248K – 1883
2023
Q4
$248K Sell
1,444
-119
-8% -$18.3K 0.01% 1264
2023
Q3
$231K Sell
1,563
-504
-24% -$91.1K 0.01% 1378
2023
Q2
$452K Sell
2,067
-295
-12% -$65.7K 0.01% 1154
2023
Q1
$517K Sell
2,362
-326
-12% -$70.7K 0.01% 1242
2022
Q4
$559K Sell
2,688
-2,918
-52% -$641K 0.01% 1131
2022
Q3
$1.22M Buy
5,606
+2,667
+91% +$607K 0.03% 782
2022
Q2
$616K Sell
2,939
-53
-2% -$11.3K 0.02% 1072
2022
Q1
$726K Sell
2,992
-2,344
-44% -$567K 0.02% 1097
2021
Q4
$1.39M Buy
+5,336
New +$1.38M 0.03% 619
2021
Q3
– Sell
-3,080
Closed -$759K – 2144
2021
Q2
$759K Sell
3,080
-17,885
-85% -$3.76M 0.02% 816
2021
Q1
$4.07M Buy
+20,965
New +$4.2M 0.15% 136

Other funds holding RMD

Boothbay Fund Management's RMD Position: Q3 2026 in Review

Boothbay Fund Management sold out of ResMed (RMD) in Q3 2026, closing a stake of 2,444 shares — an estimated $476K sold.

Boothbay Fund Management first reported a position in RMD in Q1 2021 and held it in 12 quarters. The position peaked at $4.07M in Q1 2021. 875 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Boothbay Fund Management reported no remaining ResMed position as of Q3 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 2,444 ResMed shares in Q3 2026, an estimated $476K.
  • Boothbay Fund Management first reported a position in ResMed in Q1 2021 and held it in 12 quarters.
  • Boothbay Fund Management's ResMed position peaked at $4.07M in Q1 2021.
  • 875 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Boothbay Fund Management's 13F filing for Q3 2026, filed 16 Nov 2026.